Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PhRMA Concerned About Extent Of Proposed Federal Health Board’s Authority

This article was originally published in The Pink Sheet Daily

Executive Summary

PhRMA President Billy Tauzin says it would be a “real problem” if HHS Secretary-designate Tom Daschle’s proposed federal health board made decisions that should be left to doctors and patients.

You may also be interested in...

Stimulus Bill Takes New Approach To Comparative Effectiveness Oversight

Package sets up federal-only coordinating council to give advice on comparative research activities by federal agencies.

HHS Secretary Daschle, OMB Director Orszag Set Tone For Health Reform

President-elect Barack Obama's selections of Tom Daschle for HHS secretary and current Congressional Budget Office Director Peter Orszag as head of the Office of Management and Budget accomplish at least two goals - it brings in a seasoned legislative strategist as the administration gets set to embark on health care reform and also reins in one of the party's most outspoken thinkers

IFRA Hosts Capitol Hill Scent Experience In Timeout From Policy Concerns

The International Fragrance Association North America took a break from its higher-stakes advocacy work Nov. 1 to give lawmakers and congressional staffers a "scent experience." Perfumers from six of the group's biggest members were on hand with "Scents of Home," joined by Monell Center researchers to educate attendees on the mechanics of scent and the important role it plays in people's lives.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts